Rational Drug Use 2021 (ICM2)
Rational Drug Use 2021 (ICM2)
Rational Drug Use 2021 (ICM2)
(RDU/RDT)
1. Diagnosis : 2. Prescribing :
Inadequate examination Extravagant prescribing
of patient Over-prescribing
Incomplete Incorrect prescribing
communication between
patient and doctor Under-prescribing
Lack of documented Multiple prescribing/ers
medical history
Inadequate laboratory
resources
Aspect of Irrational Drug Use
Undertreatment VS Overtreatment :
In some cases the symptom make you confuse, e.g.:
– Coughing : Patient CHF who receive ACE inhibitor
– Seizure : Patient epilepsy who take anti-epileptic drugs
How you differentiate it ??
Undertreatment / treatment inadequate
Evaluation :
– Define (specify) the therapeutic objective, determine
time & things to assess in a short time th/ to follow up
Who’s At Risk?
Everyone who uses drugs
Any period of abstinence (withdrawal)
Release from prison or jail
Any major life transition/major disappointment
Family conflict
General Symptoms
• can vary, depending on the type of drug (properties, mechanism of action)
• single or combined with another substance
23
Checklist of emergency evaluation and treatment procedures
General Treatment of a Comatose Patient
o There are several general antidotes that are used in the
treatment of comatose patients upon presentation at the
hospital.
o Consider to treat all patients who come into the hospital in
a coma with glucose, insulin and naloxone.
o Use drugs to treat emergent conditions, ie:
Seizures – anticonvulsants (benzodiazepine; lorazepam, diazepam)
Cardiac Dysrhythmias – anti-arrhythmias (amiodarone, lidocaine)
Severe Agitation – anxiolytics (short acting benzodiazepine)
25
Removal of the Drug (Emesis)
• Utilize syrup of Ipecac to Induce
emesis to remove unabsorbed drug.
• Emesis inducers
– Mechanical by stroking posterior
pharynx
– Apomorphine parenteral
– Syrup of ipecac 30 ml (1 oz) followed by
one glass of water (150-200 ml)
– Contraindications?
28
Contraindications of Emesis
29
Removal of the Drug
(Gastric Lavage)
• Gastric Lavage – washing of the
stomach. (early tx.)
30
Activated Charcoal/Cathartics
• Activated Charcoal (AC)
• Used to bind compounds and to prevent absorption in the GI
tracts. (many drugs)
• Contraindicated with caustic agents and petroleum distillates
due to the lack of adsorption of these agents by the charcoal
and risk of vomiting associated with the charcoal
• use of charcoal & ipecac concurrently not recommended
• Cathartics
• Promotes rapid passage of poison through the GI tract
• Counteracts the constipative effects of AC
• I.E. sorbitol, Mg Citrate, Mg Sulfate
31
Removal of the Drug (Other)
• Alteration of pH of urine – to enhance excretion of the drug, useful for
salicylates, chlorpropamide, etc
• Diuresis – often used in conjunction with urine pH alteration
• Dilution with water – useful in the treatment of skin or eye exposure to
harmful agents. ( no neutralizers)
• Demulcents – soothes mucous membranes and coats the stomach, i.e.
milk of magnesia
• Purgation
• Used for ingestion of enteric coated tablets when time after ingestion is
longer than one hour
• Use saline cathartics such as sodium or magnesium sulfate
• Hemodialysis – blood transverses a semipermeable membrane that is
bathed in dialysis solution or dialysate. Drugs or toxins diffuse across
this membrane. (high protein binding drugs)
32
B. Antidotal Treatments
A. Heavy Metals
Chelators (BAL, EDTA) complexes with the metals
making them inert
B. Heparin
Protamine (base) binds to acidic heparin to terminate
its action and is excreted by glomerular filtration.
C. Toxins-
Botulinum Toxin
Most potent poison known, rapidly absorbed and
prevents ACH release from nerve terminals
Tx: ABCs, lavage, emesis, charcoal, Trivalent anti-toxin
Mortality of 70% to 10% with treatment
33
• D. Organophosphates
• Pralidoxime is a nucleophillic reagent that ties up the
organophosphates and permits its excretion.
• E. Cyanide
• Binds to cytochrome oxidase, LD50= 2mg/kg
• Causes death in 1 to 15 minutes at high doses.
• Chelator is made in the body, methemoglobin
• Give Amyl Nitrites, Na Nitrite & Na Thiosulphate;
Hydroxocobalamin with O2 and whole blood .
34
DISPOSITION OF THE PATIENT
• All patients w/ potentially serious overdose, observed at least 6-8h
• Signs-symptoms of intoxication can develop during this time (due to
delayed or redistribution of the toxic agent)
• If specific drug levels are determined, obtain repeated serum levels
to be certain (should be decreasing as expected)
• Most patients will need observation ICU, depends on the potential
for serious cardiorespiratory complications.
• Patient w/ suicidal intent must be kept under close observation.
36